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A gastro retentive pH sensitive system has been a frontier approach 
to release the drug in controlled manner in stomach and duodenum. 
The aim of the study is to develop reliable formulation of amoxicillin 
which will release the drug in controlled way at specific site with  
acidic pH stimulus present  in the  gastric region.  In the present 
investigation pectin based oil entrapped micro gel beads were 
prepared by ionic gelation technique using castor oil and mineral oil. 
The developed beads were evaluated in term of diameter, surface 
morphology, floating lag time, encapsulation efficiency, in vitro drug 
release.  
Prepared microbeads were regular and spherical in shape. The 
formulation exhibited sustained release profile and was best fitted in 
the Peppas model with n < 0.45. Subsequent coating of microbeads 
exhibited zero-order sustained pattern of amoxicillin release up to 8 
hrs.  
The Results provides evidence that optimized gel bead may be used 
to incorporate antibiotics like amoxicillin and may be effective when 
administered locally in the stomach to cure microbial infection.   
Keywords: Amoxicillin (Am); Calcium pectinate bead; Residential 
time; pH Sensitive; Ethyl cellulose (EC);  
 
Introduction 
Oral route of administration still remains the 
route of choice for the majority of clinical 
application for the local action in the 
gastrointestinal tract (GI).  Recent scientific 
report and patent literature reveals,   interest in 
novel dosage forms that can be retained in the 
stomach for a prolonged and predictable period 
of time. The feasible approaches for achieving a 
prolonged and predictable drug delivery are 
control the gastric residence time (GRT), using 
gastric retentive dosage form that can provide 
newer therapeutic option[1, 2] . Floating drug and 
bioadhesive drug delivery systems are widely 
used techniques for gastroretention [3, 4]. 
Floating drug delivery systems have a bulk 
density lower than gastric fluids and thus remain 
buoyant in the stomach for a prolonged period of 
time, without affecting the gastric emptying rate. 
While the system is floating on the gastric 
contents, the drug is released slowly at a desired 
rate from the system and remaining part of the 
residual system is slowly emptied from the 
stomach and enhanced GRT of the drug [5-7]. 
This study was envisaged to develop 
mucoadhesive gastric retentive formulation of 
amoxicillin in order to achieve targeted release of 
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amoxicillin in acidic pH of the   gastrointestinal 
tract. 
The concept of multiunit gastro retentive 
microbead can be utilized to provide a more 
reliable and long lasting release of drug in the 
stomach for local and systemic action. Narkar et 
al. [8] prepared and evaluated the oral 
mucoadhesive beads of amoxicillin. Babu et al. 
[9] prepared gellan gum macro beads of 
amoxicillin. The oil entrapped pectin gel beads   
were found to be a potential candidate for 
targeted drug delivery and are anticipated to be 
useful in the treatment of microbial infection in 
the gastric region [10].  
Gastric retentive and floating approaches were 
under taken to develop reliable formulation of 
amoxicillin  that has all the advantages to modify 
the release of the drug with continuous and for 
prolonged period. Thus the formulations was    
uniform distributed in gastric site and maintain 
long time minimum inhibitory concentration 
(MIC) of the drug around microbial cell line [11].  
Amoxicillin is semi-synthetic amino penicillin 
with a broad-spectrum bactericidal activity [12, 
13]. Pectin is colloidal polygalacturonic acid in 
which some of the carboxylic group is esterified 
with methyl group [14, 15]. Pectin can reduce 
interfacial tension between oil and a water phase 
and is efficient for the preparation of emulsion 
[14]. In the present investigation, the amoxicillin –loaded 
gastroretantive emulsion gel beads of calcium pectinate 
were developed and investigated with the aim to 
achieve a gastroretentive, multiple units, and 
controlled release formulation of amoxicillin. 
 
Materials and methods  
 
Materials 
Amoxicillin was obtained as gift sample from, 
Ranboxy laboratory Devash, India. Low methoxy 
pectin with the degree of esterification of 35% 
and ethyl cellulose were obtained from S.D. Fine 
Chem. India. Light mineral oil and castor oil 






Preparation of calcium pectinate beads 
The gel beads were formulated with 23 factorial 
design patterns (Table 1). The effect of 
concentration of the oils (castor and mineral 
oils), pectin and calcium chloride (CaCl2) were 
selected as  independent variable. Effect of the 
dependent variables in the formulation was 
investigated in terms of bead diameter, floating 
lag time, encapsulation efficiency and drug 
content.  
 
Table 1: Composition of drug loaded calcium pectinate gel 
beads  
 
        Formulation      Drug     Gum     Oil       Calcium  
                                   %         %           %        chloride 
Castor      Mineral      w/v       w/v       w/v        mol ml–1 
   oil            oil   
 (COB)    (MOB) 
     S1                 P1             0.65        1.50       05         0.275 
     S2                 P2             0.65        1.50       10         0.275  
     S3                 P3             0.65        2.10       05         0.275 
     S4                 P4             0.65        1.50       05          0.450 
     S5               P5            0.65        1.50        15          0.275 
     S6                 P6             0.65        2.10        05         0.450 
     S7                 P7             0.65        1.50        15         0.450 
     S8                 P8             0.65        2.10        10         0.450 
     S9           P9         0.65        2.10         15         0.450 
 
 
COB = castor oil entrapped formulation 
MOB = mineral oil entrapped formulation   
 
Oil entrapped calcium pectinate gel beads were 
prepared by ionic gelation method.  A 0.65 % 
w/v of drug was dispersed in varying 
concentrations (1.50 -2.10 % w/v) of aqueous 
solution of pectin with continuous stirring until a 
uniform dispersion was obtained. The mixture 
was emulsified with either mineral oil or castor 
oil using Silverson emulsifier (Hicon, India) 
stirred at 500 rpm for 5 min.  
The resultant drug loaded emulsions was dropped 
through a 21G syringe needle separately into 100 
ml of 0.275- 0.45 mol ml -1 of calcium chloride 
solution, maintained under gentle agitation to 
improve the mechanical strength of the beads and 
also to prevent aggregation of the formed beads. 
Amoxicillin loaded beads containing   either 
castor oil (COB) or mineral oil (MOB) were 
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separated, washed with water and allowed to dry 
at 40 0C in side tray dryer  for 6 hrs .   
 
Particle size and morphology 
Particle size of the prepared beads were 
determined in three set using an optical 
microscope (Model BH-2, Olympus, Japan) fitted 
with a stage and an ocular micrometer. Mean 
diameter was calculated by measuring diameter 
of 20 dried beads. The external and internal 
morphology of micro gel beads were studied by 
scanning electron microscopy. The micro beads 
were coated with gold palladium under an argon 
atmosphere using a gold sputter module in a high 
vacuum evaporator. The coated samples were 
then observed with a scanning electron 
microscope. 
In vitro floating studies   
The in vitro floating study was performed using a 
USP 24 dissolution apparatus II, having 500 ml 
of phthalate buffer solution (pH 3.4). The 
medium temperature was kept at 37 ± 0.5 °C. 
The floating beads (1.0 g beads) were soaked in 
the dissolution medium and the medium was 
agitated with a paddle at 50 rpm. After agitation, 
the beads that floated on the surface of the 
medium and those that settled down at the 
bottom of the flask were recovered separately 
[15].  
 
Determination of drug loading and 
encapsulation efficiency  
 
Accurately weighed (100 mg) grounded powder 
of beads was soaked in 100 ml phosphate buffer 
(pH 7.5) and allowed to disintegrates completely 
for 4 h (16). The resulting dispersion was 
sonicated using a probe sonicator (UP 400 s, Dr. 
Hielscher GmbH, Germany) for 30 min and then 
filtered through a 0.45 μm filter. The polymeric 
debris was washed twice with fresh phosphate 
buffer to extract any adhered drug and drug 
content was determined spectrophotometrically 
at   334.5 nm against constructed a calibration 
curve. The encapsulation efficiency (EE) was 
calculated according to the relationship in Eq 1 
 
EE (%) = (C/T) x 100 …………………….  (1)     
Where C is the calculated drug content and T is 
the theoretical drug content 
 
In vitro drug release 
In vitro dissolution studies were performed for all 
the formulation gel beads using USP 24 
dissolution test apparatus II with a basket type. 
An accurately weighed 50 mg amount of the 
formulation dropped in 900 ml of both fasted 
state( simulated gastric fluid ,SGF , pH 1.2) and 
fed state (phthalate buffer solution,  pH 3.4) 
conditions maintained at a temperature of 37ºC ± 
0.5ºC and stirred at a speed of 50 rpm. At 
different time intervals, a 10 - ml aliquot of the 
sample was withdrawn at 0.5, 1.0, 2.0, 3.0, 4.0, 
5.0, 6.0, 7.0 and 8.0 hrs and the volume was 
replaced with an equivalent amount of plain 
dissolution medium. The collected samples were 
filtered and suitably diluted and analyzed at 
334.5 nm using a UV-visible spectrophotometer 
(Shimadzue). Drug release data were corrected 
for the values of the drug loss. Additionally, an 
experimental batch BF and BE containing 10 mg 
amoxicillin and lactose (q.s.) filled in a capsule 
(# 2) was used as a reference formulation. Drug 
release data were corrected for the values of the 
drug loss during sampling [17]. 
 
Gastric residence efficacy  
Gastric residence efficacy was evaluated by the 
method of Zheng et al. [18] with slight 
modification.  Albino rates selected for the study 
were fasted for 8 hrs and then divided into two 
groups and each group consisted of three 
animals.  Each group was pre-treated by an 
intraperitoneal injection of omeprazole at a 15 
mg/Kg dose to suppress gastric acid secretion. 
After 1 h of the administration of the drug each 
group was given a single oral dose of the gel 
beads 500 bead (batch P5 and S5) aqueous 
suspension. After 1, 4, and 8 hrs, the rate was 
scarified by cervical dislocation. The stomachs 
were removed. The microbeads that retained in 
the stomach were counted and the percentage of 
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Coating of gel beads 
The prepared formulation  batch S5 was selected 
for optimization due to higher  value of 
evaluations parameters like particle size , lag 
time , encapsulation efficiency , drug content and 
gastric residence time .The selected  beads  were 
coated with EC in 22 factorial designs (as table 
2.). The coating material taken as 5 - 10% w/v 
ethyl cellulose (EC) solution in acetone and 
coating time 5 - 10 min. The gel beads (2 g) were 
placed in a fluidized bed dryer (TG 100, Retsch, 
Germany) and the fluidized beads were sprayed 
with the coating solution for a period of 10 min 
at an air inlet speed of 220 m s–1 at room 
temperature. The beads were dried at room 
temperature for a period of 24 hrs until the 
solvent was evaporated, leaving a film coat on 
the gel beads. 
 
Table 2: Independent variables of the formulation bead 
coated with ethyl cellulose  
 
Formulation   EC concentration   Time of       DR480 hr      R2 
    code                 % m/v               coating 
                                                        (min)         ( % ) 
 
 S15                            5                        5            85.7        0.991 
 S25                             5                      10           69.8        0.980 
 S35                            10                       5            64.4        0.972 
 S45                            10                     10            59.2        0.971 
 
DR = dissolution efficiency 
EC = ethylcellulose concentration   
R2   = correlation coefficient, derived from zero order drug 
release kinetic. 
S15, S25, S35 and S45 = optimized ethylcellulose coated 
formulation of batch  S5 batch. 
 
Statistical analysis 
The experimental results were expressed as mean 
± SD (standard deviation). Statistical evaluation 
of data was performed using an analysis of 
variance (ANOVA) and, depending on the 
outcome of the ANOVA (Dunnett’s multiple 
comparison test).The evaluation data was used to 
assess the significance of differences. 
Statistically significant difference between the 
means of batches were defined as P<0 .05.  
 
Result and discussion                             
Morphology of microgel bead  
Gel micro beads were produce due to gelation 
and cross linking of Ca++ ions, provided a gel 
barrier at the surface of the formulation. Pectin 
helped to emulsify the mixture of water and oil 
phase during the homogenization process and its 
emulsion stabilization property could be 
explained by its surface-active ability to reduce 
the interfacial tension between the oil and water 
phases.  
Scanning electron micrograph (SEM) of 
amoxicillin loaded microgel bead and their 
surface morphology are shown in Figures 1A & 
1B. Gel beads prepared from mineral oil (MOB) 
were white, translucent and elastic, whereas 
castor oil entrapped gel beads (COB) were off -
white translucent and rigid in texture. 
 
    Table 3: Characterization of prepared formulation of calcium pectinate gel beads 
                    Formulation            Diameter                   Lag time           Encapsulation efficiency        Drug content     
                                                     (mm)  a ,b,c                   ( sec)a ,c                    (%w/w)a ,c                              %a, d, c 
              COB    MOB           MOB          COB         MOB       COB       MOB        COB                   MOB        COB 
             S1        P1              1.54±0.8     1.74±0.3     24±1.3    26± 1.5    55±0.4     57±0.6         38±1.24     49±1.14 
               S2        P2             1.62 ±0.7     1.83±0.5     32± 1.5   334±1.6   49±0.4     53±0.2        53±1.44     42±1.42 
                S3        P3            1.66±0.5      1.88±0.4     50±1.3    54±1.2     59±0.6     65±0.4         45±1.25     56±1.41 
                S4        P4            1.58±0.3      1.79±0.5     19±1.9    23 ±1.5    52±0.2     56±0.6         36±1.68     46±1.23 
                S5        P5            1.64±0.3      1.75±0.7     14±1.4    17± 1.8    65±0.6     77±0.2         56±1.46     61±1.14 
                S6        P6            1.76±0.2      1.87±0.6     20± 1.7   30±1.4     51±0.4     63±0.6         52±1.35     55±1.31 
                S7        P7            1.68±0.4      1.89±0.5     43±1.8    53±1.2     58±0.4     60±0.6         40±1.42     52±1.23 
                S8        P8            1.69±0.3      1.90±0.6     46±1.5    60±1.4     50±0.5     62±0.5         42±1.53     53±1.24 
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        (1A)                                        (1B) 
 
Figure I: External structure under electron microscope of dried 
beads of (1A) batch P5 (MOB) and (1B) batch S5 (COB). 
 
Particle Size of bead 
The effect of various formulation parameters on the 
particle size of prepared floating beads are shown 
in Table 3. The diameter of MOB formulation 
vary in size 1.54±0.8 to 1.76±0.2 mm and COB 
formulation  size was ranges 1.74±0.3  to 2.10 
±0.4 mm . Size distribution pattern of micro 
beads of both the formulation was found 
significance difference ( Figure 2).  It has been 
found that the diameter of beads increased 
significantly (P< 0.05) on  increasing 
concentration of the polymer . This could be due 
to increase in micro-viscosity of the polymeric 
dispersion eventually resulted into formation of 
bigger beads. Large size beads were form as 
concentration of CaCl2 increased, this is due   to 
generation of excess Ca+2 and resulted to 



















Figure 2: Mean particle size distribution pattern in the 
different batches of formulations MOB & COB. 
  
Lag time and buoyancy  
The time taken for the beads to float at the 
surface of the medium known as floating lag 
time. The lag time was found to vary 14-57 sec. 
(MOB formulation) and 17-66 sec. (COB 
formulation).  The minimum lag time was found 
in MOB formulation (14±1.4 sec batch P5) and 
COB formulation was 17±1.8 sec. (in batch S5).  
Buoyancy is an important characteristic in 
sustained drug delivery. On increasing   CaCl2 
concentration, floating lag time was reduced. The 
increase in the amount of Ca++ and consequently 
the amount of CO2, evolved are responsible for the 
observed reduction in floating lag time. Floating 
lag time was increased as concentration of the oil 
in the formulation increase, this could be due to 
large number of oil globules tend to stick each 
other and produce flocculation or they may unite 
and produced   coalescence in the large droplet 
form. Droplets may fill in the pores of the 
system, resulted in decrease porosity of the bead. 
 
Encapsulation efficiency and drug content  
Encapsulation  of the drug was found to be 
consistently higher in the  formulation COB of 
batch S5 (77±0.2%) and MOB formulation of 
batch P5 (65±0.6 %) . The drug contents   were 
61± 1.14 %   and 56±1.46% in  batch S5 and 
batch P5  . The encapsulation efficiency increased 
progressively with increasing polymer 
concentration .This is because of the availability 
of excess of the polymer resulted in formation of 
larger size of beads entrapping  more amount of  
the drug.  
 
Gastric residence efficacy  
Gastric residence studies were carried out to 
ensure the transit of design formulation in the 
mucosa.  Profile of the gastric residence time of 
microbead is shown in Figure 3. Gastric retention 
of selected batch S5 and batch  P5 was found 
59±1.6 %  and  54±1.2 %   respectively at  8 hrs 
of the study .Significance difference (P < 0.05)  
of gastric residence  of MOB  (batch P5) and 
COB(batch S5)  formulations was   due to affinity 
of the formulation  towards glycoproteins of the 
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mucus layer  of stomach.  The formulation was 
floated in the stomach and later adhered to the 
mucous layer so both mechanisms enhanced the 



























Figure 3: Gastric residence pattern in albino rate 
of batches S5 and P5 
 
In Vitro drug release studies  
In vitro amoxicillin  release study of gel beads was 
carried out in the fasted state (SGF solution of pH 
1.2), and in the fed state (phthalate buffer of pH 3.4) 
for a period of 8 hrs. Gel beads were  exhibited a 
biphasic amoxicillin  release profile as an initial rapid 
drug release phase (burst effect) was followed by a 
slower, gradually declining drug release phase was 
extended up to 8 hrs (Figure 4A.). The drug release 
from experimental reference (capsule was filled with  
10 mg of amoxicillin)  and  the release study  was 
90.09 ± 2.48 %  ( batch BE ) in empty state  and 
87.5±2.45%  ( batch BF ) in fed state in to  within 2 
hrs  and  could not sustain the release of the drug  
over   8 hrs. High  Release of amoxicillin  was 
found in batch S5(59 ± 2.14 % ) and batch M6 
(38± 2.43 % )  in fad  of  8 hrs  of the study.  
Various release kinetic models (zero order , 
Higuchi and Korshmaer-Peppas model)  were 
applied for the elucidation of mechanism of the 
drug release from floating gel beads in the fed 
state condition[20-22]. Drug release from the 
optimized formulations S5  followed the Higuchi 
(R2 = 0.943 ) and Peppas models (R2 = 0.986, n = 
0.36) , suggested  a diffusion based mechanism 
of drug release as the diffusion exponent values 
were less than 0.45 [19]. 
Non enteric polymer ethyl cellulose was selected 
for coating of gel beads due to its stability in 
gastric pH and based on the reports on the use of 
ethyl cellulose for coating on floating micro 
particles to modify the drug release [19]. The 
desirable dependent response showed zero-order 
release pattern from EC-coated formulation in 
the fed state.  The release of amoxicillin  from 
formulation S15 gel beads was  highest 85.7± 1.2%  
at end of 8 hrs of study ( Figure 4A). The 
formulation batch S15 exhibited maximum 
dissolution efficiency was best fitted zero-order 
release and R2 value of 0.9991 ( Table 2.) was 
optimized batch of the controlled-release 
formulation of amoxicillin. 
 
Conclusion  
Based on the results of this study, it reveals  that 
optimized ethylcellulose coated batch S15 micro 
gel beads of amoxicillin have pH sensitive  
controlled release of drug in acidic region of the 
gastrointestine. Therefore, it may be capable of 
delivering amoxicillin  to stomach sites, thus 
opening up the possibility of targeting the drug to 
gastric sites for the cure of microbial infections 
such as that caused by H. pylori.  
 
List of abbreviations  
Am, amoxicillin ; EC, ethylcellulose ; GI , 
gastrointestinal tract ; MIC, minimum inhibitory 
concentration ; COB,  castor oil entrapped 
formulation; MOB,mineral oil entrapped 
formulation;    
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